Skip to main content
. 2018 May 7;217(5):1797–1813. doi: 10.1083/jcb.201710095

Figure 6.

Figure 6.

Loss of ORP5/8 increases both PI4P and PI(4,5)P2 levels in the PM. (A) PM PI4P levels in ORP5-, ORP8-, or ORP5/8-depleted cells. HEK293-AT1 cells were transfected with control, ORP5-, ORP8-, or both ORP5- and ORP8-silencing siRNAs for 2 d and subjected to BRET analysis monitoring PM PI4P. Three independent experiments performed in triplicate were each normalized to control. Grand means ± SEM are shown. Statistical analysis was performed by two-way ANOVA (**, P < 0.005; ns, not significant). (B) Same experiments as in A except that PM PI(4,5)P2 levels were assessed by BRET measurements. (C) Effect of knockdown of ORP5/8 on PI4P levels in PIP5Kβ-expressing cells. HEK293-AT1 cells were transfected with the indicated siRNAs as in A. 1 d after siRNA transfection, cells were transfected with pcDNA3.1(HA) or myc-tagged PIP5Kβ (2 ng/well). 1 d after DNA transfection, cells were subjected to BRET measurement for PM PI4P. Statistical analysis from three independent experiments performed in triplicate was obtained as described for A. (D) Representative live-cell confocal images showing changes in PI4P distribution in response to PIP5Kβ expression in cells treated with control or ORP5/8-targeting siRNAs. HEK293-AT1 cells were transfected with indicated siRNAs. 1 d after siRNA transfection, cells were cotransfected with GFP-tagged P4M(2x) and mRFP-tagged PIP5Kβ (50 ng/well). 1 d after DNA transfection, cells were observed with a confocal microscope. Note the presence of some PI4P in the PM even in the PIP5K-expressing cells in the ORP5/8-depleted cells. Bars, 10 µm. (E) Kinetics of PM PI4P decrease after A1 treatment (left) in cells expressing PIP5Kβ with or without depletion of ORP5/8. Experiment was as described in C except for treatment of cells with A1 (30 nM) after a control measurement period. The rate of PM PI4P decrease was calculated for the time period indicated by the gray area (D). Grand means ± SEM are shown from three independent experiments performed in triplicate. Values were normalized to the rate value calculated for the vector-transfected cells treated with control siRNA. Statistical analysis was obtained with two-way ANOVA (**, P < 0.005).